1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Crohn's Disease Global Clinical Trials Review, H1, 2015

Crohn's Disease Global Clinical Trials Review, H1, 2015

  • January 2015
  • -
  • Global Data
  • -
  • 122 pages

Crohn's Disease Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Crohn's Disease Global Clinical Trials Review, H1, 2015" provides data on the Crohn’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Crohn’s Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Crohn’s Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Crohn's Disease Global Clinical Trials Review, H1, 2015
Introduction 6
Crohn's Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Crohn's Disease to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Crohn's Disease to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Crohn's Disease 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Crohn's Disease Therapeutics Clinical Trials 35
Prominent Drugs 36
Latest Clinical Trials News on Crohn's Disease 37
Dec 02, 2014: RedHill Biopharma to Sponsor and Exhibit Its Ongoing Phase III Crohn's Program at the Israeli IBD Society Meeting 37
Nov 12, 2014: TiGenix completes patient recruitment for the European Phase III trial of Cx601 ahead of schedule 37
Oct 29, 2014: Qu Biologics Crohn's Disease Clinical Trial Completes Independent Safety Review 38
Oct 22, 2014: New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease 38
Oct 20, 2014: Phase II Data in Crohn's Disease for Celgene's Oral Antisense Therapy GED-0301 to Be Presented at UEG Week 2014 39
Oct 20, 2014: ChemoCentryx Releases Phase III SHIELD 4 Clinical Results in Patients With Crohn's Disease 39
Clinical Trial Profiles 41
Clinical Trial Overview of Top Companies 41
AbbVie Inc. 41
Clinical Trial Overview of AbbVie Inc. 41
UCB S.A. 44
Clinical Trial Overview of UCB S.A. 44
Johnson and Johnson 47
Clinical Trial Overview of Johnson and Johnson 47
Pfizer Inc. 49
Clinical Trial Overview of Pfizer Inc. 49
Merck and Co., Inc. 51
Clinical Trial Overview of Merck and Co., Inc. 51
GlaxoSmithKline plc 53
Clinical Trial Overview of GlaxoSmithKline plc 53
Ferring International Center S.A. 54
Clinical Trial Overview of Ferring International Center S.A. 54
C. H. Boehringer Sohn AG and Co. KG 55
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 55
Takeda Pharmaceutical Company Limited 56
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 56
Sanofi 57
Clinical Trial Overview of Sanofi 57
Clinical Trial Overview of Top Institutes / Government 58
The National Institute of Allergy and Infectious Diseases 58
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 58
Jinling Hospital 59
Clinical Trial Overview of Jinling Hospital 59
Hyogo College Of Medicine 60
Clinical Trial Overview of Hyogo College Of Medicine 60
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 61
Clinical Trial Overview of Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 61
University of Western Ontario 62
Clinical Trial Overview of University of Western Ontario 62
University of Pittsburgh 63
Clinical Trial Overview of University of Pittsburgh 63
Vanderbilt University 64
Clinical Trial Overview of Vanderbilt University 64
University of Alberta 65
Clinical Trial Overview of University of Alberta 65
Academic Medical Center 66
Clinical Trial Overview of Academic Medical Center 66
University of British Columbia 67
Clinical Trial Overview of University of British Columbia 67
Five Key Clinical Profiles 68
Appendix 120
Abbreviations 120
Definitions 120
Research Methodology 121
Secondary Research 121
About GlobalData 122
Contact Us 122
Disclaimer 122
Source 122

List of Tables

Crohn's Disease Therapeutics, Global, Clinical Trials by Region, 2015* 7
Crohn's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Crohn's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Crohn's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Crohn's Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Crohn's Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Crohn's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Crohn's Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Crohn's Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Crohn's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Crohn's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Crohn's Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Crohn's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Crohn's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Crohn's Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Crohn's Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Crohn's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Crohn's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Crohn's Disease Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Crohn's Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Crohn's Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Crohn's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Crohn's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 33
Crohn's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 34
Crohn's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 35
Crohn's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 36
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 41
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2015* 44
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 47
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 49
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 51
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 53
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015* 54
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2015* 55
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 56
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 57
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 58
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Jinling Hospital, 2015* 59
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2015* 60
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, 2015* 61
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Western Ontario, 2015* 62
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2015* 63
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 64
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2015* 65
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 66
Crohn's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2015* 67

List of Figures

Crohn's Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Crohn's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Crohn's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Crohn's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Crohn's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Crohn's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Crohn's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Crohn's Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Crohn's Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Crohn's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Crohn's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Crohn's Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Crohn's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Crohn's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Crohn's Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Crohn's Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Crohn's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Crohn's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Crohn's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Crohn's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 33
Crohn's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 34
Crohn's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 35
Crohn's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 36
GlobalData Methodology 121

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Liver Cirrhosis- Market Insights, Epidemiology and Market Forecast-2023

Liver Cirrhosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Liver Cirrhosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Peptic Ulcer  - Market Insights, Epidemiology and Market Forecast-2023

Peptic Ulcer  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Peptic Ulcer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Crohn’s disease (CD)- Market Insights, Epidemiology and Market Forecast-2023

Crohn’s disease (CD)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Crohn’s disease (CD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.